Sandra Lindstedt Selected Research

Heart Rupture

4/2015	C-reactive protein and leucocyte counts drop faster using the HeartShield® device in patients with DSWI.
1/2014	The Duration of Negative Pressure Wound Therapy Can Be Reduced Using the HeartShield Device in Patients With Deep Sternal Wound Infection.
1/2013	A protective device for negative-pressure therapy in patients with mediastinitis.
10/2011	Effects on drainage of the mediastinum and pleura during negative pressure wound therapy when using a rigid barrier to prevent heart rupture.
8/2011	Haemodynamic effects of negative pressure wound therapy when using a rigid barrier to prevent heart rupture.
7/2011	A rigid barrier between the heart and sternum protects the heart and lungs against rupture during negative pressure wound therapy.
3/2011	Sternum wound contraction and distension during negative pressure wound therapy when using a rigid disc to prevent heart and lung rupture.
2/2009	Haemodynamic effects of -75 mmHg negative pressure therapy in a porcine sternotomy wound model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra Lindstedt Research Topics

Disease

23	Wounds and Injuries (Trauma) 02/2015 - 12/2007
8	Heart Rupture 04/2015 - 02/2009
7	Bronchiolitis Obliterans Syndrome 01/2022 - 01/2009
5	Rupture 03/2014 - 02/2011
4	Inflammation (Inflammations) 03/2022 - 12/2011
4	Thrombosis (Thrombus) 10/2017 - 10/2013
4	Death (Near-Death Experience) 10/2017 - 01/2015
4	Hemorrhage 03/2014 - 02/2011
4	Mediastinitis 01/2013 - 10/2008
3	Primary Graft Dysfunction 04/2022 - 05/2015
3	Infections 01/2021 - 10/2006
3	Wound Infection (Wound Infections) 01/2014 - 02/2011
2	Asthma (Bronchial Asthma) 03/2022 - 01/2022
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021 - 01/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Stroke (Strokes) 01/2020 - 09/2016
2	Ventricular Fibrillation 11/2016 - 10/2015
2	Glucose Intolerance 09/2014 - 06/2012
2	Pain (Aches) 01/2012 - 12/2011
1	Allergic Rhinitis 01/2022
1	Lung Diseases (Lung Disease) 12/2021
1	Carotid Artery Diseases 10/2021
1	Aortic Coarctation 10/2021
1	Hyperemia 10/2021
1	Congenital Heart Defects (Congenital Heart Defect) 09/2021
1	Thymoma (Thymic Carcinoma) 01/2021
1	Colonic Polyps 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	COVID-19 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Lung Injury 01/2021
1	Neoplasms (Cancer) 07/2020
1	Lung Neoplasms (Lung Cancer) 07/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Ischemia 09/2016
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Insulin Resistance 09/2014
1	Type 2 Diabetes Mellitus (MODY) 11/2010
1	Prostatic Neoplasms (Prostate Cancer) 10/2006

Drug/Important Bio-Agent (IBA)

4	dicarboxydine (DCD)IBA 10/2017 - 01/2015
3	Heparin (Liquaemin)FDA LinkGeneric 11/2016 - 10/2013
2	Prostaglandins DIBA 04/2022 - 05/2015
2	CytokinesIBA 03/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Propofol (Diprivan)FDA LinkGeneric 01/2020 - 09/2016
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 09/2016
2	Glucose (Dextrose)FDA LinkGeneric 09/2014 - 06/2012
2	polyurethane foamIBA 12/2011 - 02/2011
1	Interleukin-13IBA 03/2022
1	Interleukin-4 (Interleukin 4)IBA 03/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Small Untranslated RNAIBA 01/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Coenzyme A (CoA)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2021
1	Vitamin K FDA Link 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2020
1	Pharmaceutical PreparationsIBA 07/2020
1	LigandsIBA 07/2020
1	SolutionsIBA 10/2017
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2017
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	C-Reactive ProteinIBA 04/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	EnzymesIBA 09/2014
1	Insulin (Novolin)FDA Link 06/2012
1	Substance PIBA 12/2011
1	Calcitonin Gene-Related PeptideIBA 12/2011
1	NeuropeptidesIBA 12/2011
1	Protect-ItIBA 08/2011
1	ParaffinIBA 02/2011
1	TeaIBA 11/2010
1	Biological ProductsIBA 10/2010
1	Prostate-Specific Antigen (Semenogelase)IBA 10/2006
1	Ciprofloxacin (Cipro)FDA LinkGeneric 10/2006

Therapy/Procedure

24	Negative-Pressure Wound Therapy 04/2015 - 12/2008
14	Therapeutics 01/2022 - 12/2007
7	Sternotomy 08/2011 - 12/2008
6	Lung Transplantation 04/2022 - 10/2013
4	Transplantation 12/2021 - 01/2009
2	Artificial Respiration (Mechanical Ventilation) 04/2022 - 12/2019
2	Warm Ischemia 10/2015 - 01/2015
2	Traction 03/2011 - 03/2011
1	Extracorporeal Membrane Oxygenation 01/2021
1	Contraindications 01/2021
1	Anesthesia 09/2016
1	Ligation 09/2016
1	Inhalation Anesthesia 09/2016
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2015
1	Tissue and Organ Harvesting 10/2013
1	Protective Devices (Safety Device) 01/2013
1	Debridement 02/2011
1	Catheters 10/2010
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2008